BMF Antikörper (N-Term)
(2 Referenzen)-
- Target Alle BMF Antikörper anzeigen
- BMF (Bcl2 Modifying Factor (BMF))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BMF Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunocytochemistry (ICC)
- Verwendungszweck
- Rabbit polyclonal antibody raised against synthetic peptide of BMF.
- Spezifität
- HepG2 or 293 cell lysate can be used as a positive control and a band at approximately 25 KDa can be detected. It is human and mouse reactive.
- Kreuzreaktivität
- Human, Maus
- Immunogen
- A synthetic peptide corresponding to N-terminus 15 amino acids of human BMF.
- Top Product
- Discover our top product BMF Primärantikörper
-
anti-Bcl2 Modifying Factor (BMF) (AA 1-181) antibody
BMF Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Bcl2 Modifying Factor (BMF) (AA 112-126), (AA 13-27) antibodyBMF Reaktivität: Maus, Ratte WB, IHC, ELISA, IP, ICC, FACS Wirt: Ratte Monoclonal 17A9 unconjugated
anti-Bcl2 Modifying Factor (BMF) (AA 130-150) antibodyBMF Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Bcl2 Modifying Factor (BMF) (AA 7-156) antibodyBMF Reaktivität: Human WB, IHC (p), IF Wirt: Kaninchen Polyclonal unconjugated
anti-Bcl2 Modifying Factor (BMF) (AA 115-150) antibodyBMF Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB00594 unconjugated
anti-Bcl2 Modifying Factor (BMF) (AA 1-184) antibodyBMF Reaktivität: Human IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Bcl2 Modifying Factor (BMF) (AA 1-184) antibodyBMF Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Bcl2 Modifying Factor (BMF) (N-Term) antibodyBMF Reaktivität: Human, Maus WB, IF, EIA Wirt: Kaninchen Polyclonal unconjugated
anti-Bcl2 Modifying Factor (BMF) (AA 130-150), (BH3 Domain) antibodyBMF Reaktivität: Human WB, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
anti-Bcl2 Modifying Factor (BMF) (BH3 Domain) antibodyBMF Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Western Blot (2 μg/mL)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- In PBS (0.02 % sodium azide)
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Store at 4°C for three months. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
: "Apoptosis. Till death us do part." in: Science (New York, N.Y.), Vol. 293, Issue 5536, pp. 1784-5, (2001) (PubMed).
: "Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis." in: Science (New York, N.Y.), Vol. 293, Issue 5536, pp. 1829-32, (2001) (PubMed).
-
: "Apoptosis. Till death us do part." in: Science (New York, N.Y.), Vol. 293, Issue 5536, pp. 1784-5, (2001) (PubMed).
-
- Target
- BMF (Bcl2 Modifying Factor (BMF))
- Andere Bezeichnung
- BMF (BMF Produkte)
- Synonyme
- BMF antikoerper, AW260063 antikoerper, AW411872 antikoerper, Bcl2 modifying factor antikoerper, Bcl2 modifying factor L homeolog antikoerper, BCL2 modifying factor antikoerper, BMF antikoerper, bmf.L antikoerper, Bmf antikoerper
- Gen-ID
- 90427
-
